These data along with our data from the GBM tissue array and intracranial xenograft model of brain tumors may support a strategy for targeting the miR-211/MMP-9 interaction or rescuing miR-211 expression as a new therapeutic application to treat GBM patients in the future. This evidence concerns the gene MMP9 and brain neoplasm.